short term trading - week starting: 24th sept, page-83

GTG keep an eye on this now cleared for BREVAGen Breast Cancer Screen test sales in 8 States. Just waiting on NY state then the rest of the other 50 can become sales permit inclusions. See today's ann. for quick update, Florida was the 2nd of the big state triology required - California, Florida and NY. [It is also a bit complicated by the medicare rebate system that will be available to 42 of those states.]

This will be a FA trigger dependent on NY approval not TA.

The lead will also come from Nasdaq [GENE] ADR sales [GTG= 30:1=GENE] tonight and then on NY permit.